Monopar Therapeutics (MNPR) Other Working Capital Changes (2017 - 2020)
Historic Other Working Capital Changes for Monopar Therapeutics (MNPR) over the last 4 years, with Q3 2020 value amounting to $76609.0.
- Monopar Therapeutics' Other Working Capital Changes rose 92624.03% to $76609.0 in Q3 2020 from the same period last year, while for Sep 2020 it was -$59419.0, marking a year-over-year increase of 4680.48%. This contributed to the annual value of $21792.0 for FY2024, which is 677.12% up from last year.
- Latest data reveals that Monopar Therapeutics reported Other Working Capital Changes of $76609.0 as of Q3 2020, which was up 92624.03% from -$164342.0 recorded in Q2 2020.
- Monopar Therapeutics' Other Working Capital Changes' 5-year high stood at $139557.0 during Q4 2017, with a 5-year trough of -$164342.0 in Q2 2020.
- In the last 4 years, Monopar Therapeutics' Other Working Capital Changes had a median value of -$1704.0 in 2017 and averaged $5055.4.
- Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 252811.03% in 2018, then crashed by 210209.03% in 2020.
- Over the past 4 years, Monopar Therapeutics' Other Working Capital Changes (Quarter) stood at $139557.0 in 2017, then tumbled by 183.36% to -$116330.0 in 2018, then skyrocketed by 88.16% to -$13770.0 in 2019, then surged by 656.35% to $76609.0 in 2020.
- Its Other Working Capital Changes stands at $76609.0 for Q3 2020, versus -$164342.0 for Q2 2020 and $42084.0 for Q1 2020.